Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity - Stock Option Activity (Detail)

v3.25.2
Stockholders' Equity - Stock Option Activity (Detail)
6 Months Ended 12 Months Ended
May 31, 2025
USD ($)
$ / shares
shares
Nov. 30, 2024
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted 103,000  
Service-Based Vesting Condition Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding at November 30, 2023 493,878  
Granted 103,000  
Exercised 0  
Expired/forfeited (45,000)  
Outstanding at May 31, 2024 551,878 493,878
Exercisable at May 31, 2024 425,995  
Outstanding at November 30, 2023, Weighted Average Exercise Price | $ / shares $ 7.26  
Granted, Weighted Average Exercise Price | $ / shares 7.89  
Exercised, Weighted Average Exercise Price | $ / shares 0  
Expired/forfeited, Weighted Average Exercise Price | $ / shares 13.48  
Outstanding at May 31, 2024, Weighted Average Exercise Price | $ / shares 6.87 $ 7.26
Exercisable at May 31, 2024, Weighted Average Exercise Price | $ / shares $ 6.83  
Outstanding, Weighted Average Remaining Contractual Term (Years) 3 years 10 months 17 days 3 years 9 months 29 days
Exercisable at May 31, 2024, Weighted Average Remaining Contractual Term (Years) 3 years 9 months 10 days  
Outstanding at November 30, 2023, Aggregate Intrinsic Value | $ $ 997,943  
Granted, Aggregate Intrinsic Value | $ 0  
Exercised, Aggregate Intrinsic Value | $ 0  
Expired/forfeited, Aggregate Intrinsic Value | $ 0  
Outstanding at May 31, 2024, Aggregate Intrinsic Value | $ 74,152 $ 997,943
Exercisable at May 31, 2024, Aggregate Intrinsic Value | $ $ 67,055